The Manufacturers Life Insurance Company Has $48.88 Million Stake in HCA Healthcare, Inc. $HCA

The Manufacturers Life Insurance Company reduced its stake in HCA Healthcare, Inc. (NYSE:HCA) by 9.8% in the 1st quarter, Holdings Channel reports. The firm owned 103,294 shares of the company’s stock after selling 11,244 shares during the period. The Manufacturers Life Insurance Company’s holdings in HCA Healthcare were worth $48,883,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also modified their holdings of HCA. Brighton Jones LLC acquired a new position in HCA Healthcare during the 4th quarter worth $1,021,000. NewEdge Advisors LLC increased its stake in shares of HCA Healthcare by 11.9% in the first quarter. NewEdge Advisors LLC now owns 3,859 shares of the company’s stock worth $1,334,000 after purchasing an additional 409 shares during the period. Sivia Capital Partners LLC boosted its stake in HCA Healthcare by 5.5% during the 2nd quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock valued at $241,000 after purchasing an additional 33 shares during the period. Jump Financial LLC bought a new position in HCA Healthcare in the 2nd quarter worth approximately $2,073,000. Finally, Sei Investments Co. boosted its position in shares of HCA Healthcare by 56.3% in the second quarter. Sei Investments Co. now owns 136,589 shares of the company’s stock valued at $52,328,000 after acquiring an additional 49,214 shares during the period. 62.73% of the stock is currently owned by institutional investors and hedge funds.

HCA Healthcare Stock Down 2.9%

NYSE:HCA opened at $396.15 on Friday. The firm has a 50-day moving average price of $386.88 and a 200 day moving average price of $451.49. The firm has a market capitalization of $85.77 billion, a PE ratio of 13.26, a price-to-earnings-growth ratio of 1.42 and a beta of 1.12. HCA Healthcare, Inc. has a 12-month low of $353.13 and a 12-month high of $556.52.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Friday, July 24th. The company reported $7.59 earnings per share for the quarter, beating the consensus estimate of $7.56 by $0.03. The company had revenue of $20.23 billion for the quarter, compared to analyst estimates of $19.76 billion. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The company’s revenue was up 8.7% compared to the same quarter last year. During the same period in the prior year, the company posted $6.84 EPS. On average, research analysts expect that HCA Healthcare, Inc. will post 29.38 EPS for the current year.

HCA Healthcare Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Wednesday, September 16th will be paid a $0.78 dividend. This represents a $3.12 annualized dividend and a dividend yield of 0.8%. The ex-dividend date is Wednesday, September 16th. HCA Healthcare’s payout ratio is currently 10.45%.

Analyst Upgrades and Downgrades

HCA has been the subject of several research analyst reports. Raymond James Financial set a $528.00 target price on shares of HCA Healthcare in a research note on Tuesday, July 7th. Wall Street Zen downgraded shares of HCA Healthcare from a “buy” rating to a “hold” rating in a report on Saturday, May 2nd. Sanford C. Bernstein reissued a “market perform” rating on shares of HCA Healthcare in a research report on Wednesday, July 15th. Leerink Partners cut their price target on HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating for the company in a report on Monday, April 27th. Finally, Stephens lowered their price objective on HCA Healthcare from $560.00 to $530.00 and set an “overweight” rating on the stock in a research report on Monday, April 27th. Fourteen investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $465.05.

HCA Healthcare News Summary

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: RBC Capital reiterated its “Outperform” rating, signaling continued confidence in HCA’s long-term outlook despite recent volatility. Royal Bank of Canada Reiterates Outperform Rating for HCA Healthcare
• Positive Sentiment: HCA recently reported quarterly earnings and revenue above analyst expectations, with revenue growth of 8.7% year over year, providing a fundamental counterpoint to the stock’s recent weakness.
• Neutral Sentiment: HCA continued strengthening its hospital leadership team, appointing a former Banner Health physician executive as chief medical officer at an HCA Texas hospital and naming a former Oak Hill Hospital executive to lead two Tampa-area hospitals. Former Banner physician executive joins HCA Texas hospital HCA taps former Oak Hill Hospital executive
• Neutral Sentiment: An upcoming open house for HCA’s Long Point emergency room highlights local expansion and community outreach, but is unlikely to materially affect near-term earnings. HCA Long Point ER Open House
• Negative Sentiment: A North Carolina judge cleared the attorney general’s lawsuit against HCA to proceed to trial and separately rejected a key HCA argument concerning its obligations to provide services at Mission Hospital. The cases could create legal costs, operational restrictions, or reputational damage. Judge clears path to trial for NC attorney general lawsuit against HCA
• Negative Sentiment: Dogwood Health Trust also flagged potential compliance concerns in its review of HCA’s Mission Health operations, adding to investor uncertainty around the North Carolina dispute. Dogwood Health Trust flags HCA compliance concerns
• Negative Sentiment: Mizuho, KeyCorp, Truist, and Robert W. Baird lowered their expectations or price targets for HCA. KeyCorp reduced its target to $435, reinforcing concerns about valuation, industry conditions, or legal overhangs. Mizuho lowers expectations for HCA KeyCorp lowers HCA price target Baird issues pessimistic forecast for HCA
• Negative Sentiment: Pomerantz LLP announced an investigation into potential claims on behalf of HCA investors, which may further weigh on sentiment even though the announcement does not establish wrongdoing. Pomerantz investor investigation into HCA

About HCA Healthcare

HCA Healthcare is a for?profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.